Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674264 · ClinicalTrials.gov registry record · NA
Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD
A NA study, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT07674264 is a NA study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 32 participants.
The verdict
NCT07674264, a NA study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Parkinsonism impairs upper airway and axial motor control, leading to disordered breathing, reduced speech volume, and ineffective cough. Symptoms are poorly addressed by current therapies. This randomized pilot trial tests whether a single session of acute intermittent hypercapnic hypoxia (AIHH) or hypercapnic normoxia (AIHN) improves upper airway and axial motor function in Parkinsonism, and explores biomarker correlates of intervention responsiveness.
Interventions
- OTHER Acute intermittent hypercapnic hypoxia (AIHH)
- OTHER Acute intermittent hypercapnic normoxia (AIHN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-06-20 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07674264
The ClinicalTrials.gov registry entry for NCT07674264 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acute intermittent hypercapnic hypoxia (AIHH) is the first listed.
NCT07674264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07674264 about?
NCT07674264 is a clinical study titled "Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD". Parkinsonism impairs upper airway and axial motor control, leading to disordered breathing, reduced speech volume, and ineffective cough. Symptoms are poorly addressed by current therapies. This randomized pilot trial tests whether a single session of acute intermittent hypercapnic hypoxia (AIHH) or...
What is the current status of trial NCT07674264?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-06-20. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07674264?
The interventions under investigation include: Acute intermittent hypercapnic hypoxia (AIHH) (OTHER), Acute intermittent hypercapnic normoxia (AIHN) (OTHER).
Who is sponsoring clinical trial NCT07674264?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.